about
Activation of human B-MYB by cyclinsPkn is a novel partner of cyclin T2a in muscle differentiationCoexpression of Helicobacter pylori's proteins CagA and HspB induces cell proliferation in AGS gastric epithelial cells, independently from the bacterial infection.E1A deregulates the centrosome cycle in a Ran GTPase-dependent manner.Who is the boss in the retinoblastoma family? The point of view of Rb2/p130, the little brother.The bad and the good of mesenchymal stem cells in cancer: Boosters of tumor growth and vehicles for targeted delivery of anticancer agents.cDNA array technology in melanoma: an overview.Genetic and epigenetic alterations as hallmarks of the intricate road to cancer.Emerging roles of DNA tumor viruses in cell proliferation: new insights into genomic instability.Determination of SGK1 mRNA in non-small cell lung cancer samples underlines high expression in squamous cell carcinomasHepatitis C virus core protein modulates pRb2/p130 expression in human hepatocellular carcinoma cell lines through promoter methylationPreclinical model in HCC: the SGK1 kinase inhibitor SI113 blocks tumor progression in vitro and in vivo and synergizes with radiotherapyRetinoblastoma family proteins as key targets of the small DNA virus oncoproteins.SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells.Interaction between the human papillomavirus 16 E7 oncoprotein and gelsolin ignites cancer cell motility and invasiveness.Gender-related disparities in non-small cell lung cancer.Wasting lives: the effects of toxic waste exposure on health. The case of Campania, Southern Italy.New insights in endometrial carcinogenesis.Understanding the targeting of the RB family proteins by viral oncoproteins to defeat their oncogenic machinery.Identification of protein-protein interactions of human HtrA1.SI113, a specific inhibitor of the Sgk1 kinase activity that counteracts cancer cell proliferation.Cathepsin B inhibition interferes with metastatic potential of human melanoma: an in vitro and in vivo studySgk1 activates MDM2-dependent p53 degradation and affects cell proliferation, survival, and differentiation.Multiple interference of the human papillomavirus-16 E7 oncoprotein with the functional role of the metastasis suppressor Nm23-H1 protein.Ferritin light chain down-modulation generates depigmentation in human metastatic melanoma cells by influencing tyrosinase maturation.In vitro and in vivo tumor growth inhibition by a p16-mimicking peptide in p16INK4A-defective, pRb-positive human melanoma cells.Defective human retinoblastoma protein identified by lack of interaction with the E1A oncoprotein.Glucose utilization by tumor cells: a post-translational modification of mitochondrial hexokinase may play a regulatory role.Cytotoxic effect of the association of BCNU with rhein or lonidamine on a human glioma cell line.Antiproliferative effect of lonidamine on a human glioblastoma multiforme cell line.Correlation between melanogenic and catalase activity in in vitro human melanocytes: a synergic strategy against oxidative stress.Glycolysis and growth rate in normal and in hexokinase-transfected NIH-3T3 cells.Protein synthetic activity and adenylate energy charge in Rhein-treated cultured human glioma cells.rp-120: a common endogenous substrate for insulin and IGF-1 receptor-associated tyrosine kinase activity in the highly malignant AS-30D rat hepatoma cells.The serine protease HtrA1 is upregulated in the human placenta during pregnancy.Intracellular presence of insulin and its phosphorylated receptor in non-small cell lung cancer.Protease-mediated arsenic prodrug strategy in cancer and infectious diseases: a hypothesis for targeted activation.The small molecule SI113 synergizes with mitotic spindle poisons in arresting the growth of human glioblastoma multiforme.Drug repurposing for the treatment of glioblastoma multiforme.Lonidamine in the combined treatment of malignant gliomas. A randomized study.
P50
Q24674836-2BF54B96-06C1-4D78-9E21-DD4F85988E85Q28119183-49106155-6C7F-46AA-9607-0913CFCE91E4Q31012209-703C59FA-53DC-4B84-AF8E-62F18CFB8D56Q33292372-9C7D80F5-2BC2-49E8-B8E3-B2436B69D196Q34282661-1DF011C7-95D5-4E4D-845C-46295599707CQ34992255-62FBE9F7-678B-4417-BBC9-9CDB2B78C007Q35156687-EE8EFB4B-5D0F-4C9C-B8DE-AF49FCB9BC51Q35551099-B15EEA27-89B9-4094-B7D6-D4A69BEB6C38Q35551117-9270A3A6-6C50-4C30-9558-8952AA3519F7Q35771966-1B132E90-64DC-4A70-B4B1-626FA257810DQ36294409-DDDD091F-2B4F-437B-9FF4-D6D5FF3D93FDQ36545796-B66A02D2-EB1A-44B5-9F0A-B918EF35A5F3Q36579274-49518075-C9BA-4235-921E-D29F61EFA0BCQ37085905-9D9386C5-C23B-4B5B-A63E-70D25226392DQ37588229-9654A0C6-FAAA-4BF5-AF35-0F597A60E339Q37786414-094A346E-2E26-4A70-9D71-3FDC591FAD39Q37898432-13CE9700-7A09-4C91-860E-196F905CF2B5Q37959376-7C936B67-0745-4684-B2C4-855E1E57D73EQ38020415-34FEA225-6551-4F7B-B126-13D17EE64C5EQ38334796-30F60B24-D1D9-4CFA-A25E-7F2C8DE2B9C8Q38887535-A5BC7D13-8769-45DA-82AD-BAAB2F59C7F3Q39671546-0D3B8065-1C9D-4DD7-BBF3-15ED3F091E39Q39799247-8169BA96-FD6A-4626-BEF0-D1DB1E241213Q40208771-20EC8567-F1A5-4673-8A81-4C963EC1F02FQ40357586-3FEA1D2D-8418-4473-B3EE-7D8A69E72996Q40511673-1684C841-EB8F-4EFC-A348-1F63DB920185Q41487058-F044C63A-EB22-402B-98A1-157E8002F090Q41673696-3D490A33-0317-4243-A1A3-3822E597A3F9Q41694560-72C3C357-66EC-4B03-A847-92D1ACB89EFEQ41729894-0B6F8DDD-2C87-4A50-BEA6-795FE8CF6E68Q42435123-A785E740-1D56-4088-B6B6-3A595B6D4F82Q42803675-F8D322D1-286A-4D7C-9E20-E67E5F3017B0Q44476339-B83FCBA8-9A03-45D2-ACC0-34CBF6E6BAB2Q44595021-21C9BD59-0966-42DD-9B2D-CDEE770C63EFQ44945496-109E34BD-58C8-4A19-A232-895440A720FAQ46781616-67D2B12F-7D66-4865-9EE9-1454B24EB9B3Q46982668-AD45C716-D8C8-48D1-871B-22DEDCB6583EQ47861000-628B398A-5F68-4A68-ACB0-43BA4A2D66EBQ47948290-13570512-DC76-4F0C-B170-301253815F68Q48946506-B9E95D04-54BB-40DA-A5A5-37984F8E52F9
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
M G Paggi
@ast
M G Paggi
@en
M G Paggi
@es
M G Paggi
@nl
type
label
M G Paggi
@ast
M G Paggi
@en
M G Paggi
@es
M G Paggi
@nl
prefLabel
M G Paggi
@ast
M G Paggi
@en
M G Paggi
@es
M G Paggi
@nl
P31
P496
0000-0002-9445-442X